Tesamorelin 5mg — Vial Spec, Reconstitution Math & COA

Overview of the 5mg Vial Specification and Laboratory Utility

A standard 5mg vial of Tesamorelin contains 5 milligrams of highly purified synthetic peptide cake, lyophilized under high-vacuum conditions to preserve structural stability. This specific fill volume is typically ordered by research facilities conducting mid-scale preclinical trials or high-throughput in vitro binding assays where a moderate quantity of peptide must be reconstituted for standardized dosing protocols.

As a synthetic growth-hormone-releasing hormone (GHRH) analog, Tesamorelin is widely investigated for its ability to selectively bind and activate pituitary GHRH receptors. Research teams utilize this 5mg format to ensure precise concentration management without subjecting excessive active compound to repeated freeze-thaw cycles. To review all active formulations available for laboratory inquiry, explore our complete catalog of research peptides.

Structural Profile and GHRH Mechanism in Preclinical Models

Tesamorelin is a trans-3-hexenoic acid derivative of human growth hormone-releasing hormone (GHRH 1-44). The addition of the hexenoyl group to the N-terminal amino acid sequence enhances metabolic stability against rapid enzymatic degradation by dipeptidyl peptidase-IV (DPP-IV) compared to native GHRH. Preclinical studies suggest that this structural modification prolongs the circulating half-life of the molecule in animal models while maintaining high binding affinity for the GHRH receptor.

In cell culture and rodent models, activation of the GHRH receptor by Tesamorelin initiates a signal transduction cascade through the G-protein alpha subunit, stimulating intracellular cyclic adenosine monophosphate (cAMP) production. In vitro data indicate that this cascade promotes the transcription and pulsatile secretion of endogenous growth hormone (GH), subsequently elevating downstream hepatic insulin-like growth factor 1 (IGF-1) expression. Scientists analyze these pathway dynamics to evaluate metabolic regulation, lipolysis parameters, and tissue-repair mechanisms in experimental settings. Detailed mechanistic whitepapers can be reviewed in the PX1 research library.

Reconstitution Dilution Mathematics for 5mg Lyophilized Mass

Accurate concentration calculations are vital for maintaining protocol reproducibility across experimental assays. When working with a 5mg lyophilized vial of Tesamorelin, the volume of diluent—typically Bacteriostatic Water or Sterile Normal Saline (0.9% NaCl)—determines the final working concentration per volumetric unit. To streamline concentration modeling before laboratory preparation, researchers frequently consult our inline reconstitution calculator.

The mathematical relationship follows the standard formula: Concentration = Mass / Volume. Below are the precise baseline concentrations achieved when reconstituting a 5mg vial with standard laboratory diluent volumes:

1.0 mL Diluent Addition: Reconstituting 5mg (5,000 mcg) of lyophilized powder with 1.0 mL of liquid yields a concentration of 5.0 mg/mL (500 mcg per 0.1 mL / 100 units). This concentrated matrix is ideal for small-volume micro-injection assays in animal models where volume restriction is critical.

2.0 mL Diluent Addition: Adding 2.0 mL of diluent to 5mg yields a working concentration of 2.5 mg/mL (250 mcg per 0.1 mL / 100 units). This moderate concentration offers an optimal balance between precision measuring and fluid volume for repeated administration protocols in preclinical settings.

3.0 mL Diluent Addition: Adding 3.0 mL of diluent yields a final concentration of approximately 1.67 mg/mL (166.7 mcg per 0.1 mL / 100 units). Diluting to this volume reduces volumetric measurement error when transferring sub-milligram quantities to cell culture wells or microfluidic platforms.

Aliquot Planning and Laboratory Handling Protocols

To prevent batch degradation, re-crystallization, or loss of biological activity, laboratories utilizing 5mg Tesamorelin vials must execute structured aliquot strategies immediately following complete dissolution. Repeated freeze-thaw cycles severely compromise the peptide's tertiary structural integrity and promote aggregation, which distorts assay quantification.

Upon gentle reconstitution—allowing the diluent to trickle down the inner glass wall of the vial followed by slow rotation (never vigorous vortexing)—the liquid should be divided into sterile, low-protein-binding microcentrifuge tubes. Aliquots should be volume-calibrated according to daily experimental consumption metrics. Each aliquot must be labeled with the lot number, reconstitution date, and exact concentration before immediate transfer to ultra-low storage conditions.

Thermal Stability and Storage Constraints

Lyophilized Tesamorelin displays excellent long-term physical stability when stored under climate-controlled conditions. Unopened 5mg vials should be kept in a desiccated environment at freezer temperatures (-20°C to -80°C) protected from light exposure, where the peptide mass remains stable for up to 24 months. Standard refrigerated storage (2°C to 8°C) is acceptable for short-term holds prior to assay setup.

Once reconstituted into aqueous solution, the peptide bond structure becomes significantly more sensitive to heat and mechanical agitation. Reconstituted Tesamorelin solution must be maintained continuously at refrigerated temperatures (2°C to 8°C) and utilized within 14 to 28 days depending on the bacteriostatic preservative used. Unpreserved sterile water reconstitutions must be utilized or aliquoted and frozen immediately within 24 hours to prevent microbial proliferation and hydrolysis.

Analytical Verification: Lot-Matched COA and HPLC/MS Standards

To guarantee valid, reproducible scientific outcomes, PX1 Research subjects every production lot to comprehensive third-party analytical testing. Research compounds must meet strict identity and purity metrics before release to scientific institutions. Laboratory managers can independently verify batch data by requesting a lot-specific certificate of analysis (COA).

Purity assessment is performed via High-Performance Liquid Chromatography (HPLC), ensuring that the active Tesamorelin peak accounts for ≥98% of total integrated area, with trace synthesis counter-ions fully quantified. Mass Spectrometry (MS) is simultaneously utilized to verify the exact molecular mass against theoretical sequence expectations. Furthermore, bacterial endotoxin testing via Limulus Amebocyte Lysate (LAL) assay confirms that endotoxin content remains strictly below <0.01 EU/mg, minimizing extraneous inflammatory variables in delicate in vitro and animal models.

Comparative Analysis: Tesamorelin vs. Related GHRH and GHRP Compounds

When designing protocols investigating the GH/IGF-1 axis, research teams frequently evaluate multiple secretagogues to compare receptor kinetics, half-life, and downstream physiological cascades. Tesamorelin is distinct in its specific N-terminal modification, providing enhanced resistance to enzymatic cleavage while maintaining selective GHRH receptor selectivity.

In contrast, other GHRH derivatives such as CJC-1295 DAC incorporate a Drug Affinity Complex that covalently binds to circulating serum albumin, extending its biological half-life significantly beyond that of Tesamorelin. Meanwhile, short-acting analogs like Sermorelin represent truncated 29-amino-acid sequences with faster elimination clearance. When studying synergistic GH pulse elevation, laboratories often combine GHRH agonists with selective growth hormone secretagogue receptor (GHSR) agonists like Ipamorelin, which trigger GH release through distinct pathways without elevating cortisol or prolactin.

Vial Format Selection: 5mg vs. 10mg Mass Considerations

Selecting the correct vial size depends entirely on the design, duration, and subject size of the planned research project. A 5mg vial format provides an optimal quantity for preliminary dose-response studies, short-duration animal cohorts, or multi-well cell culture assays where keeping reagent batches fresh is paramount.

For large-scale, ongoing animal studies requiring continuous daily administration over several weeks, single 5mg vials may require frequent reconstitution, introducing handling variability. In such high-throughput contexts, utilizing larger unit sizes reduces per-milligram supply overhead and minimizes container-closure interventions. Note: While PX1 Research standardizes its primary catalog inventory on the larger, highly economical Tesamorelin 10mg format, laboratory accounts requiring custom bulk fills or specific 5mg unit packaging can consult our wholesale portal for specialized procurement.

Preclinical Applications in Metabolic and Tissue Repair Models

Preclinical research involving Tesamorelin focuses heavily on metabolic regulation, visceral adipose tissue dynamics, and cellular repair pathways. Because growth hormone and IGF-1 mediate lipid oxidation and protein synthesis, researchers utilize Tesamorelin to investigate targeted lipolysis in models of metabolic dysfunction.

In rodent models of diet-induced obesity and hepatic steatosis, preclinical studies suggest that administration of GHRH analogs like Tesamorelin leads to measurable reductions in visceral fat mass and decreases in intrahepatic triglyceride accumulation. Furthermore, in vitro data indicate that elevated downstream IGF-1 expression supports satellite cell proliferation and extracellular matrix remodeling, providing a foundational baseline for tissue-repair research.

PX1 Quality Assurance and Supply Chain Standards

PX1 Research operates as a premier supplier of laboratory-grade research compounds across the United States. Every batch of peptide is manufactured in state-of-the-art, GMP-compliant facilities and verified by accredited ISO 17025 laboratories to guarantee absolute consistency across scientific investigations.

To support rigorous research timelines, PX1 maintains fully stocked distribution centers in California and Arizona, offering same-day dispatch for orders placed Monday through Friday before 3:00 PM PST. All orders arrive in temperature-monitored, protective packaging designed to preserve peptide stability during transit, ensuring that researchers receive uncompromised reagents ready for immediate reconstitution and assay integration.